Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · IEX Real-Time Price · USD
14.02
-1.59 (-10.19%)
At close: Jul 2, 2024, 4:00 PM
14.72
+0.70 (4.99%)
After-hours: Jul 2, 2024, 7:19 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $461.89 million as of July 2, 2024.
Market Cap
461.89M
Enterprise Value
274.82M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.02
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $461.89M, an increase of 70.22%. That is a compound annual growth rate of 123.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 514.30M | 43.82% |
| Dec 29, 2023 | 357.60M | 31.78% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 532.78M |
| Third Harmonic Bio | 532.34M |
| Aveanna Healthcare Holdings | 530.97M |
| Y-mAbs Therapeutics | 530.10M |
| Entrada Therapeutics | 529.05M |
| Heron Therapeutics | 527.29M |
| PepGen | 517.38M |
| Annexon | 516.53M |